Advertisement

Topics

EC grants marketing authorisation for Allergan’s Truberzi to treat IBS-D

19:00 EDT 22 Sep 2016 | Pharmaceutical Technology

The European Commission (EC) has granted marketing authorisation for Allergan’s Truberzi (eluxadoline) in Europe.

Original Article: EC grants marketing authorisation for Allergan’s Truberzi to treat IBS-D

NEXT ARTICLE

More From BioPortfolio on "EC grants marketing authorisation for Allergan’s Truberzi to treat IBS-D"

Quick Search
Advertisement